CN Patent

CN102625696B — 改进的脂质制剂

Assigned to Tek Mira Pharmaceutical Co · Expires 2015-06-03 · 11y expired

What this patent protects

本发明表征式(I)的阳离子脂质、包含式I的阳离子脂质的改进的脂质制剂和相应的使用方法，其中式I为 还公开了靶向脂质和包含此类靶向脂质的特定脂质制剂。

USPTO Abstract

本发明表征式(I)的阳离子脂质、包含式I的阳离子脂质的改进的脂质制剂和相应的使用方法，其中式I为 还公开了靶向脂质和包含此类靶向脂质的特定脂质制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102625696B
Jurisdiction
CN
Classification
—
Expires
2015-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Tek Mira Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.